Headlines for Repros Therapeutics, Inc. http://www.rssboard.org/rss-specification Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/06/3691199/repros-therapeutics-prices-3-75m-share-offering-at-19-00share.aspx?source=itxwebtxt0000015 Benzinga Wed, 19 Jun 2013 20:03:53 GMT http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130618-000135&cid=1244&source=itxwebtxt0000015 Smart Money Tue, 18 Jun 2013 06:42:59 GMT http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/100077/repros-to-conduct-phase-iib-trial.aspx?source=itxwebtxt0000015 Zacks Thu, 23 May 2013 22:35:01 GMT http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3613921/fda-recommends-running-phase-2b-trial-of-repros-proellex-v.aspx?source=itxwebtxt0000015 Benzinga Wed, 22 May 2013 20:18:35 GMT http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11919096/1/biotech-stock-mailbag-synta-zogenix-sarepta-amarin.html.aspx?puc=aol&cm_ven=aol&source=itxwebtxt0000015 TheStreet Fri, 10 May 2013 07:00:00 GMT http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11918232/1/repros-patent-problems-began-when-harry-met-joe.html.aspx?puc=aol&cm_ven=aol&source=itxwebtxt0000015 TheStreet Thu, 09 May 2013 08:00:00 GMT http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1361151-shorts-are-covering-these-4-highly-shorted-cash-rich-small-caps.aspx?source=itxwebtxt0000015 Seeking Alpha Tue, 23 Apr 2013 09:10:04 GMT http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96992/repros-gets-additional-patents.aspx?source=itxwebtxt0000015 Zacks Fri, 12 Apr 2013 16:40:01 GMT http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1324871-5-stocks-to-watch-next-week-for-gains.aspx?source=itxwebtxt0000015 Seeking Alpha Sun, 07 Apr 2013 03:32:23 GMT http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96334/positive-data-on-repros-androxal.aspx?source=itxwebtxt0000015 Zacks Thu, 04 Apr 2013 16:43:01 GMT http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1321121-can-repros-therapeutics-maintain-its-momentum.aspx?source=itxwebtxt0000015 Seeking Alpha Thu, 04 Apr 2013 13:14:12 GMT http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/28/up-76-overnight-with-room-to-run/.aspx?source=itxwebtxt0000015 DailyFinance Thu, 28 Mar 2013 17:49:00 GMT http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11882690/1/repros-ceo-my-testosterone-drug-helped-gay-cubans-have-lots-of-sex.html.aspx?puc=aol&cm_ven=aol&source=itxwebtxt0000015 TheStreet Thu, 28 Mar 2013 12:10:00 GMT http://www.fool.com/news/xt/marketwatch/www.marketwatch.com/story/thursdays-movers-blackberry-accenture-2013-03-28.aspx?mod=247wallst&source=itxwebtxt0000015 MarketWatch Thu, 28 Mar 2013 10:36:04 GMT http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3454869/morning-market-movers.aspx?source=itxwebtxt0000015 Benzinga Thu, 28 Mar 2013 10:09:43 GMT http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3452865/repros-reports-both-primary-endpoints-successfully-met-in-androxal-study.aspx?source=itxwebtxt0000015 Benzinga Wed, 27 Mar 2013 21:45:49 GMT http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1269891-repros-therapeutics-za-301-study-odds-of-success-have-just-increased.aspx?source=itxwebtxt0000015 Seeking Alpha Wed, 13 Mar 2013 11:20:46 GMT http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3377293/repros-therapeutics-says-fda-granted-end-of-phase-2-meeting-in-late-may-to-discus.aspx?source=itxwebtxt0000015 Benzinga Thu, 28 Feb 2013 09:29:11 GMT http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/23/this-week-in-biotech-16/.aspx?source=itxwebtxt0000015 DailyFinance Sat, 23 Feb 2013 12:00:00 GMT http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/21/repros-soars-and-abbvie-might-suffer/.aspx?source=itxwebtxt0000015 DailyFinance Thu, 21 Feb 2013 16:25:00 GMT